Skeptical About China's Stimulus Plan

Eric Marshall, of Hodges Capital Management, shares his favorite small cap plays.

Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.

Douglas Roberts, of ChannelCapitalResearch.com, and Dean Barber, of the Barber Financial Group, share their investment strategies and favorite sectors with CNBC.

A check on the markets with Bernard McSherry, of Cuttone & Co., and Doug Prskalo, of Blue Capital Group.